Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

被引：0
|
作者：
Llewellyn Mills
Adrian Dunlop
Mark Montebello
Jan Copeland
Raimondo Bruno
Meryem Jefferies
Iain Mcgregor
Nicholas Lintzeris
机构：
[1] South East Sydney Local Health District,Drug and Alcohol Services
[2] University of Sydney,Specialty of Addiction Medicine, Faculty Medicine, and Health
[3] National Drug and Alcohol Research Centre,NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN)
[4] University of New South Wales,Drug and Alcohol Services
[5] NSW Health,Priority Research Centre for Brain and Mental Health, School of Medicine and Public Health
[6] Hunter New England Local Health District,Drug and Alcohol Services
[7] University of Newcastle,Mind and Neuroscience
[8] Northern Sydney Local Health District, Thompson Institute
[9] University of the Sunshine Coast,Drug Health
[10] University of Tasmania,School of Psychology
[11] Western Sydney Local Health District,Lambert Initiative Cannabinoid Therapeutics
[12] University Sydney,undefined
[13] University Sydney,undefined
来源：
Substance Abuse Treatment, Prevention, and Policy | / 17卷
关键词：
Cannabis use disorder; Cannabis dependence; Treatment outcomes; Treatment engagement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
    Mills, Llewellyn
    Dunlop, Adrian
    Montebello, Mark
    Copeland, Jan
    Bruno, Raimondo
    Jefferies, Meryem
    Mcgregor, Iain
    Lintzeris, Nicholas
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2022, 17 (01)
  • [2] Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder
    Wang, Ruoyu
    Trigo, Jose M.
    Le Foll, Bernard
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (08): : 5228 - 5238
  • [3] Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
    Lees, Rachel
    Hines, Lindsey A. A.
    Hindocha, Chandni
    Baio, Gianluca
    Shaban, Natacha D. C.
    Stothart, George
    Mofeez, Ali
    Morgan, Celia J. A.
    Curran, H. Valerie
    Freeman, Tom P. P.
    PSYCHOPHARMACOLOGY, 2023, 240 (02) : 337 - 346
  • [4] Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
    Rachel Lees
    Lindsey A. Hines
    Chandni Hindocha
    Gianluca Baio
    Natacha D. C. Shaban
    George Stothart
    Ali Mofeez
    Celia J. A. Morgan
    H. Valerie Curran
    Tom P. Freeman
    Psychopharmacology, 2023, 240 : 337 - 346
  • [5] Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial
    Montebello, Mark
    Jefferies, Meryem
    Mills, Llewellyn
    Bruno, Raimondo
    Copeland, Jan
    McGregor, Iain
    Rivas, Consuelo
    Jackson, Melissa A.
    Silsbury, Catherine
    Dunlop, Adrian
    Lintzeris, Nicholas
    DRUG AND ALCOHOL DEPENDENCE, 2022, 234
  • [6] Non-abstinent treatment outcomes for cannabis use disorder
    Levin, Frances R.
    Mariani, John J.
    Choi, C. Jean
    Basaraba, Cale
    Brooks, Daniel J.
    Brezing, Christina A.
    Pavlicova, Martina
    DRUG AND ALCOHOL DEPENDENCE, 2021, 225
  • [7] Treatment outcomes among pregnant women with cannabis use disorder
    Kitsantas, Panagiota
    Gimm, Gilbert
    Aljoudi, Salman M.
    ADDICTIVE BEHAVIORS, 2023, 144
  • [8] A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
    Anjali K. Bhardwaj
    Llew Mills
    Michael Doyle
    Arshman Sahid
    Mark Montebello
    Lauren Monds
    Shalini Arunogiri
    Paul Haber
    Valentina Lorenzetti
    Dan I. Lubman
    Peter Malouf
    Mary E. Harrod
    Adrian Dunlop
    Tom Freeman
    Nicholas Lintzeris
    BMC Psychiatry, 24
  • [9] Quetiapine treatment for cannabis use disorder
    Mariani, John J.
    Pavlicova, Martina
    Choi, C. Jean
    Basaraba, Cale
    Carpenter, Kenneth M.
    Mahony, Amy L.
    Brooks, Daniel J.
    Bisaga, Adam
    Naqvi, Nasir
    Nunes, Edward, V
    Levin, Frances R.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 218
  • [10] A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
    Bhardwaj, Anjali K.
    Mills, Llew
    Doyle, Michael
    Sahid, Arshman
    Montebello, Mark
    Monds, Lauren
    Arunogiri, Shalini
    Haber, Paul
    Lorenzetti, Valentina
    Lubman, Dan I.
    Malouf, Peter
    Harrod, Mary E.
    Dunlop, Adrian
    Freeman, Tom
    Lintzeris, Nicholas
    BMC PSYCHIATRY, 2024, 24 (01)
12345